Japan Coronary Artery Bypass Graft Market Size, Share, and COVID-19 Impact Analysis, By Product (Grafts, Retractors, Heart Positioners, Tissue Stabilizers, and Other Products), By Surgery Type (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery), By End Use (Hospitals, Cardiology Centers, and Other End Users), and Japan Coronary Artery Bypass Graft Market Insights, Industry Trend, Forecasts to 2035

Japan Coronary Artery Bypass Grafts Market Insights Forecasts to 2035

• The Japan Coronary Artery Bypass Graft Market Size Was Estimated at USD 743.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.8% from 2025 to 2035
• The Japan Coronary Artery Bypass Graft Market Size is Expected to Reach USD 2078.7 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Japan coronary artery bypass graft market is anticipated to reach USD 2078.7 million by 2035, growing at a CAGR of 9.8% from 2025 to 2035. The Japan coronary artery bypass graft market increases as a result of population aging, increases in coronary artery disease incidence, and technological advances in surgery. Off-pump and minimally invasive surgical methods improve the growth of the market by increasing outcomes and reducing recovery time.

Report Coverage

This research report categorizes the market for the Japan coronary artery bypass graft market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan coronary artery bypass graft market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan coronary artery bypass graft market.

Driving Factors

The Japan coronary artery bypass graft (CABG) market is driven by a rapidly growing aging population, with approximately 29% of the population aged 65 years and above, resulting in increasing cases of coronary artery disease (CAD). Lifestyle behaviors such as a physically inactive lifestyle, diabetes, and obesity are also reasons for high CAD. Innovations and advances in technology, including off-pump CABG, minimally invasive techniques, and robot-supported surgery, improve outcomes and recovery. Increasing awareness, government efforts through healthcare infrastructure investments, and favorable reimbursement policies also fuel market growth.

Restraining Factors

The Japan coronary artery bypass graft (CABG) market is restrained by high procedure expenses, complication risks, and extended hospital stay periods. High preference towards less invasive PCI procedures, dearth of qualified surgeons, and rigorous regulatory clearances, along with reimbursement inconsistencies, also restrain market growth.

Market Segmentation

The Japan coronary artery bypass graft market share is classified into product, surgery type, and end use.

• The grafts segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan coronary artery bypass graft market is segmented by product into grafts, retractors, heart positioners, tissue stabilizers, and other products. Among these, the grafts segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to their conclusive function in the restoration of blood circulation during surgery. Their requirement is driven by the developments in drug-eluting and biocompatible grafts, which improve surgical outcomes, reduce complications, and meet the rising CABG procedures nationally.

• The single CABG surgery segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan coronary artery bypass graft market is segmented by surgery type into single CABG surgery, double CABG surgery, triple CABG surgery, and quadruple CABG surgery. Among these, the single CABG surgery segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to the minimal invasive CABG, performed using small incisions is more in vogue with the advent of surgical robots that are capable of performing precise, complex surgeries. More and more older populations, who are more prone to coronary artery disease, prefer single CABG for single lesions because it is less risky and more efficient.

• The hospitals segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan coronary artery bypass graft market is segmented by end use into hospitals, cardiology centers, and other end users. Among these, the hospitals segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to their specialty equipment, like advanced heart-lung machines, ICUs, and specialty operating rooms. Most multi-vessel disease, common in CAD, entails surgery in a controlled environment of a hospital by seasoned surgical teams to bring safety, precision, and optimal patient results from complex procedures.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan coronary artery bypass graft market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Terumo Corporation
• Stryker Corporation
• LivaNova PLC
• Getinge AB
• Boston Scientific Corp
• Abiomed Inc
• Edwards Lifesciences
• Medtronic PLC
• Abbott Laboratories
• Teleflex Incorporated
• MAQUET Holding B.V. and Co. KG
• Senko Medical Instrument Manufacturing Co, Ltd
• Others

Recent Developments:

• In January 2025, Boston Scientific received approval from Japan’s MHLW to market its PROMUS Everolimus-Eluting Coronary Stent System for coronary artery disease. The PROMUS Stent improves its DES portfolio alongside TAXUS Liberté and offers physicians a drug choice. Launch is expected post-reimbursement approval, backed by strong clinical evidence and worldwide usage.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan coronary artery bypass graft market based on the below-mentioned segments:

Japan Coronary Artery Bypass Graft Market, By Product

• Grafts
• Retractors
• Heart Positioners
• Tissue Stabilizers
• Other Products

Japan Coronary Artery Bypass Graft Market, By Surgery Type

• Single CABG Surgery
• Double CABG Surgery
• Triple CABG Surgery
• Quadruple CABG Surgery

Japan Coronary Artery Bypass Graft Market, By End Use

• Hospitals
• Cardiology Centers
• Other End Users